side effects glp 1 agonist The expanding role of GLP-1 receptor agonists: a narrative review of current evidence and future directions Is GLP-1 the Same as
Description
Risk of Retained Gastric Contents in Patients Using GLP-1RAs or Tirzepatide Presenting for Endoscopy or General Anesthesia Retrospective studies suggest that individuals on GLP-1-based therapy (exenatide, liraglutide, dulaglutide, semaglutide, or tirzepatide) appear to be at an increased risk of having retained gastric contents [Supplementary Table S3 (21)
Anesthesia providers assess this risk and may implement protective strategies based on individual patient factors
It enhances glucose-dependent insulin secretion, keeping blood sugar stable without the hypoglycemic crashes that drive cravings
This results in greater weight-loss outcomes
[DOI] [PMC free article] [PubMed] [Google Scholar] 45.Maselli D.B., Lee D., Bi D., et al
